NDAINTRAVENOUSINJECTABLE
Approved
Feb 2001
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE) (multiple vitamins injection) by Novartis. Approved for vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition (). First approved in 2001.
Drug data last refreshed 2d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
INFUVITE PEDIATRIC is a multiple vitamins injection administered intravenously as a pharmacy bulk package for pediatric patients up to 11 years of age. It prevents and treats vitamin deficiency in children receiving parenteral nutrition support. The product delivers essential vitamins through direct IV administration to patients unable to receive oral nutrition.
LOE Approaching
As LOE approaches, the brand team is likely focused on lifecycle extension strategies and managing competitive pressure, with limited growth opportunities ahead.
Mechanism of Action
Pharmacologic Class:
Vitamin C
Career Relevance
Only 2 linked job openings indicate a small, stable team managing a mature product with limited growth prospects. Career advancement on this product is likely modest, though roles in clinical operations and scientific development offer exposure to parenteral formulation expertise and pediatric specialty pharmacy operations.
Worked on INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE) at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.